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Propolis is a natural mixture of compounds produced by various bee species, including stingless bees. This compound has been
shown to exhibit antioxidant, antiproliferative, and antitumor activities. The present study aimed to determine the chemical
constituents as well as the antioxidant, cytotoxic, and toxic activities of ethanol extracts of propolis obtained from the stingless
bees Scaptotrigona depilis and Melipona quadrifasciata anthidioides, which are found in Brazil. Phytosterols, terpenes, phenolic
compounds, and tocopherol were identified in the ethanol extracts of propolis (EEPs) in different concentrations. The compounds
stigmasterol, taraxasterol, vanilic acid, caffeic acid, quercetin, luteolin, and apigenin were found only in EEP-M. The EEPs were
able to scavenge the free radicals 2,2-diphenyl-1-picrylhydrazyl and 2,2󸀠-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) and
protected human erythrocytes against lipid peroxidation, with the latter effect being demonstrated by their antihemolytic activity
and inhibition of malondialdehyde formation. The EEPs showed cytotoxic activity against erythroleukemic cells and necrosis was
the main mechanism of death observed. In addition, the concentrations at which the EEPs were cytotoxic were not toxic against
Caenorhabditis elegans. In this context, it is concluded that EEP-S and EEP-M show antioxidant and cytotoxic activities and are
promising bioactive mixtures for the control of diseases associated with oxidative stress and tumor cell proliferation.
1. Introduction
Stingless bees, also known as meliponini, belong to the tribe
Meliponini and are distributed across more than 32 genera
[1]. Most species in this group exhibit eusocial habits and are
found in tropical and subtropical regions, and 244 species
have been described in Brazil [2, 3].
This group of bees plays an important ecological role,
contributing to the preservation of plant species through
pollination. Moreover, they produce pollen, honey, wax, and
propolis, which are used in the hive and are consumed by
humans as nutraceuticals [4–6]. Among these compounds,
propolis is obtained through the collection of exudates from
different parts of plants and combined with salivary enzymes
from bees, resulting in a resinous material that is used to
repair cracks and damage to the hive, defend againstmicroor-
ganisms, and mummify the bodies of other insects [7, 8].
Propolis is generally composed of 50% to 60% resins and
balsams, 30% to 40% waxes, 5% to 10% essential oils, and
5% pollen grains and micronutrients, with small amounts of
vitamins B1, B2, B6, C, and E [9]. The color and chemical
composition of this resin vary depending on the plant species
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from which bees collect the raw material and the bee species
that produces it [8].
Therefore, studies on propolis collected from different
geographical regions and bee species are of great importance
because these elements affect the chemical composition and,
consequently, the biological properties of propolis.
The therapeutic activity of propolis from stingless bees
has beenwidely investigated in recent decades, including des-
criptions of its antioxidant activity [10–12], antimicrobial acti-
vity [5, 13, 14], anti-inflammatory activity [15, 16], and anti-
tumor activity [7, 12, 17].
Among bee species, Scaptotrigona depilis, popularly
known as “mandaguari” andMelipona quadrifasciata anthid-
ioides, known as “mandac¸aia,” are stingless species found
in South American countries including Paraguay, Argentina,
and Brazil [1] and their genetic and behavioral characteristics
have been well described [18–21]. However, studies on the
biological activity of propolis in these species are scarce in
the literature, particularly in view of the difficulty in finding
colonies in their natural environment, where species are dis-
appearing because of anthropogenic activity.
The pharmacological properties of propolis in these
two species were evaluated by Velikova et al. [13], who
described the antimicrobial activity of propolis extracts from
M. q. anthidioides, and by Sawaya [10] who described the
antioxidant activity of propolis extracts from S. depilis. In this
context, the present study aimed to determine the chemical
constituents as well as the antioxidant, cytotoxic, and toxic
activities of ethanol extracts of propolis from the stingless bee
species S. depilis andM. q. anthidioides from the state ofMato
Grosso do Sul in Midwest Brazil.
2. Materials and Methods
2.1. Research Ethics. No specific permits were required for the
described field studies. All field works to collect the propolis
samples were conducted on private land and with owner
permission. The field studies did not involve endangered or
protected species.Theprotocol to collect of humanperipheral
blood was approved by the Research Ethics Committee
(Comiteˆ de E´tica em Pesquisa; CEP) of the University
Center of GrandeDourados (CentroUniversita´rio daGrande
Dourados; UNIGRAN), Brazil (CEP process number 123/12).
All subjects provided written informed consent for participa-
tion.
2.2. Preparation of the Ethanol Extract of Propolis (EEPs).
Propolis samples from S. depilis (83.81 g) and M. q. anthid-
ioides (36.42 g) were collected from the state of Mato Grosso
do Sul (22∘13󸀠12󸀠󸀠S–54∘49󸀠2󸀠󸀠W), in the Midwest Region of
Brazil, with a total of seven collections being performed for
each species. The ethanol extract of propolis (EEPs) was
prepared using 4.5mL of 80% ethanol per 1 g of propolis.This
mixture was incubated in a water bath at 70∘C in a sealed
container until total dissolution and subsequently filtered in
filter paper qualitative 80 g/m2 (Prolab, Sa˜o Paulo, Brazil) to
obtain the EEPs of S. depilis (EEP-S) and M. q. anthidioides
(EEP-M) [22]. After preparation of the extracts, they were
kept at a temperature of −20∘C until analysis.
2.3. Chemical Analysis
2.3.1. Preparation of the Samples. The samples (1mg) was
fractionated with hexane and water in proportion 1 : 1 v : v
and fraction soluble in hexane was analyzed by GC-MS and
fraction in water by HPLC.
2.3.2. GC-MS. Samples were injected and analyzed by gas
chromatography-mass spectrometry (GC-MS). The GC-MS
analysis was performed on a gas chromatograph (GC-2010
Plus Shimadzu Kyoto Japan) equipped with amass spectrom-
eter detector (GC-MS Ultra 2010) using LM-5 (5% phenyl
dimethyl poly siloxane) capillary column (15m length ×
0.2mm i.d. and 0.2 𝜇m film thickness) with initial oven
temperature set at 150∘C and heating from 150∘C to 280∘C at
15∘Cmin−1 and a hold at 280∘C for 15min. The carrier gas
was helium (99.99%) supplied at a flow rate of 1.0mL/min,
with split ratio 1 : 20, 1 𝜇L injection volume.The injector tem-
perature was 280∘C and the quadrupole detector temperature
was 280∘C. The MS scan parameters included an electron-
impact ionization voltage of 70 eVmass range of 45–600𝑚/𝑧
and scan interval of 0.3 s. The identifications were completed
by comparing the mass spectra obtained in the NIST21
and WILEY229 libraries. In some cases, the compound was
confirmed by comparison of standards. Standards of the stig-
masterol,𝛽-sitosterol,𝛽-amyrin,𝛼-amyrin,𝛽-amyrin acetate,
and tocopherol (Sigma-Aldrich with purity ≥97%) were pre-
pared in the concentration initial of 1000 𝜇g/mL.The concen-
trations of compoundswere determined by extern calibration
after dilutions appropriated in the range of 0.1–50 𝜇g/mL.The
quantification of taraxasterol was performed in relation to
stigmasterol. The procedure was performed in triplicate.
2.3.3. HPLC. The extracts were analyzed in an analytical
HPLC (LC-6AD, Shimadzu, Kyoto, Japan) system with a
diode array detector (DAD) monitored at 𝜆 = 200–600 nm.
TheHPLC column was a C-18 (25 cm × 4.6mm; particle size,
5 𝜇m; Luna, Phenomenex, Torrance, CA, USA), with a small
precolumn (2.5 cm × 3mm) containing the same packing,
used to protect the analytical column. In each analysis, the
flow rate and the injected volume were set as 1.0mLmin−1
and 20 𝜇L, respectively. All chromatographic analyses were
performed at 22∘C. Elution was carried out using an binary
mobile phase of water with 6% acetic acid and 2mM sodium
acetate (eluent A) and acetonitrile (eluent B). The following
applied gradients are as follows: 5%B (0min), 15%B (30min),
50%B (35min), and 100%B (45min). Standards of the vanilic
acid, caffeic acid, ferulic acid, p-coumaric acid, benzoic acid,
cinnamic acid, quercetin, luteolin, apigenin, and vanillin
(Sigma-Aldrich, ≥97%) were prepared in the concentration
initial of 1000𝜇g/mL.The concentrations of compoundswere
determined by extern calibration after dilutions appropriated
in the range of 0.01–10 𝜇g/mL.The procedure was performed
in triplicate.
2.4. Antioxidant Activity
2.4.1. DPPH Free Radical Scavenging Activity. The free
radical-scavenger activity was determined by the DPPH
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(2,2-diphenyl-1-picrylhydrazyl) assay, as described previously
by D. Gupta and R. K. Gupta [23] with some modifications.
The antiradical activity of extracts was evaluated using a
dilution series, in order to obtain a large spectrum of sample
concentrations. This involved the mixing of 1.8mL of DPPH
solution (0.11mMDPPH in 80% ethanol) with 0.2mLof EEP-
S or EEP-M (1–300 𝜇g/mL), followed by homogenization.
After 30min, quantification of the remaining DPPH radicals
was recorded by using absorption set at 517 nm. Ascorbic
acid and butylated hydroxytoluene (BHT) were used as
reference antioxidants.The tests were performed in duplicate
in 2 independent experiments. DPPH solution without the
tested sample was used as control. The percentage inhibition
was calculated from the control with the following equa-
tion:
Scavenging activity (%) = (1 − Abs sample
Abs control
) × 100. (1)
2.4.2. ABTS Free Radical Scavenging Activity. Free radical
scavenging capacity for EEP was studied as described by
Re et al. [24], through the evaluation of the free radical
scavenging effect on 2,2󸀠-azinobis-(3-ethylbenzothiazoline-
6-sulfonic acid) (ABTS) radical.The stock solutions included
7mM ABTS solution and 140mM potassium persulfate
solution. The ABTS∙+ radical was then prepared by mixing
the two stock solutions (5mL of ABTS solution and 88𝜇L
potassium persulfate solution) and left for 12–16 h at room
temperature in the dark. The solution was then diluted by
mixing 1mL ABTS∙+ radical with ethanol absolute to obtain
an absorbance of 0.70 nm ± 0.05 units at 734 nm using
a spectrophotometer. Then, 20𝜇L of EEP-S or EEP-M (1–
300 𝜇g/mL) was mixed with 1980𝜇L of the ABTS∙+ radical
and the absorbance was taken at 734 nm after 6min using
a spectrophotometer. Ascorbic acid and butylated hydroxy-
toluene (BHT) were used as positive controls.Three indepen-
dent experiments were performed in triplicate. The percent-
age of inhibition of theABTS radical was calculated according
to the following equation, where Abscontrol is the absorb-
ance of ABTS∙+ radical without the tested sample:
% inhibition of ABTS
= ((Abscontrol − Abssample)
Abscontrol
) × 100. (2)
2.4.3. Antioxidant Assay Using the Human Erythrocyte Model
(1) Preparation of Erythrocyte Suspensions. Following ap-
proval by the Research Ethics Committee, 20mL of periph-
eral blood was collected from healthy donors into sodium
citrate-containing tubes and was subsequently centrifuged at
1500 rpm for 10min. After centrifugation, the blood plasma
and leukocyte layers were discarded, and the erythrocytes
were washed 3 times with saline solution and centrifuged
at 1500 rpm for 10min. Finally, 10% erythrocyte suspensions
were prepared in saline solution to obtain 2.5% after the
treatment.
(2) Oxidative Hemolysis Inhibition Assay.The protective effect
of the propolis extracts was evaluated according to the
method described by Campos et al. [12], with minor modi-
fications. The assays were conducted with erythrocyte sus-
pensions. The erythrocytes were preincubated at 37∘C for
30min in the presence of different concentrations of EEP
or ascorbic acid (50–125 𝜇g/mL). Then, 50mM 2,2󸀠-azobis-
(2-amidinopropane) dihydrochloride (AAPH) solution was
added. A sample of 1 % ethanol was used as a negative control.
Total hemolysis was induced by incubating erythrocytes
with distilled water. Basal hemolysis caused by EEP was
assessed by incubating erythrocytes with the extract without
the presence of AAPH, and the control was assessed in
erythrocytes incubated only with 0.9% NaCl. This mixture
was incubated at 37∘C for 240 min, with periodical stirring.
Hemolysis was determined after every 120, 180, and of 240
minutes of incubation; specifically, sample were centrifuged
at 1500 rpm for 10min and aliquots of there were transferred
to tubes with saline, after which the absorbance of the super-
natant was read spectrophotometrically at 540 nm. The
percentage hemolysis was measured with the formula 𝐴/𝐵 ×100, where (𝐴) is the sample absorbance and (𝐵) is the total
hemolysis. Five independent experiments were performed in
duplicate.
(3) Inhibitory Efficiency against Lipid Peroxidation. A 2.5%
erythrocyte suspension was used to assess the protective
effects of EEP against lipid peroxidation as described by
Campos et al. [12] with some modifications. Erythrocytes
were preincubated at 37∘C for 30min with different concen-
trations of EEPs or ascorbic acid (50–125𝜇g/mL). A sample
of 1% ethanol was used as a negative control. Next, 50mM
AAPHwas added to the erythrocyte solution, whichwas then
incubated at 37∘C for 4 hours with periodical stirring. At
120, 180, and 240 minutes of incubation, the samples were
centrifuged at 1500 rpm for 10min, and 500𝜇L aliquots of the
supernatant were transferred to tubes with 1mL of 10 nmol
thiobarbituric acid (TBA). As a standard control, 500𝜇L of
20mMmalondialdehyde (MDA) solution was added to 1mL
of TBA. The samples were incubated at 96∘C for 45min. The
samples were then cooled, 4mL of n-butyl alcohol was added
and the samples were centrifuged at 3000 rpm for 5min. The
absorbance of supernatants sample was read at 532 nm.Three
independent experiments were performed in duplicate.MDA
levels in the samples were expressed in nmol/mL, obtained
with the following formula:
MDA = Abs sample × (20 × 220.32
Abs standard
) . (3)
2.5. Cytotoxic Activity and Cell Death Profile. K562 erythro-
leukemia cells line was grown is suspension in RPMI 1640
media (Cultilab, Campinas, Sa˜o Paulo, Brazil) supplemented
with 10% fetal bovine serum (FBS; Cultilab), 100U/mL of
penicillin, and 100 𝜇g/mL of streptomycin in a humidified
atmosphere at 37∘C in 5% CO
2
. The cytotoxic activity and
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cell death profile were evaluated according to the method
described by Paredes-Gamero et al. [25], with minor mod-
ifications. Cells were seeded into 96-well plates (2 × 104
cell/well) and cultured in medium with 10% FBS in the
absence or presence of EEP-S or EEP-M (31–500𝜇g/mL) for
24 h. As negative controls were used cells were incubatedwith
0.2% ethanol (highest concentration of ethanol in extract).
All effects of the EEPs were compared with negative controls.
After this period, the K562 cells were washed with PBS
and resuspended in annexin-labeling buffer (0.01M HEPES,
pH 7.4, 0.14M NaCl, and 2.5mM CaCl
2
). The suspensions
were stained with annexin-FITC and propidium iodide (PI)
(Becton Dickinson, Franklin Lakes, NJ, USA), according to
the manufacture’s instructions. The cells were incubated at
room temperature for 15min. Three thousand events were
collected per sample, and the analyses were performed on
a FACSCalibur flow cytometer (Becton Dickinson) with
CellQuest software (Becton Dickinson).
2.6. In Vivo Toxicity
2.6.1. Rearing and Maintenance of Caenorhabditis elegans.
To perform the in vivo toxicity assay, we used the wild-
type N2 strain of the nematode Caenorhabditis elegans. The
specimens were incubated at 20∘C in Petri dishes contain-
ing nematode growth medium (NGM) agar and fed with
Escherichia coli strain OP50-1. The nematode culture was
synchronized through treatment of pregnant hermaphrodites
with 2% sodium hypochlorite and 5M sodium hydroxide.
2.6.2. Assessment of Toxicity in C. elegans. A toxicity assay
for the EEPs was performed in C. elegans [26] in 96-well
plates. Each well contained 10 nematodes at the L4 stage,
which were incubated for 24 hours at 20∘C with EEP-S and
EEP-M at different concentrations (250–1000𝜇g/mL) in M9
medium. After this period, nematode viability was evaluated
by repeatedly touching the worms with a microspatula. For
the manipulation and examination of nematodes, a model
Motic SMZ-140 & W10X/23 (British Columbia, Canada)
stereomicroscope was used. The data were calculated from
two independent experiments in duplicate.
2.7. Statistical Analyses. All data are shown as the mean ±
standard error of mean (SEM) and for statistical significant
differences between the groups, using the analysis of variance
(ANOVA) and posttest Dunnett, comparing the treatment
with the control, using the Prism 6 GraphPad software. The
results were considered significant when 𝑝 < 0.05.
3. Results
3.1. Chemical Composition. The compounds identified in
EEP-S and EEP-M are shown in Tables 1 and 2. Phytosterols,
terpenes, phenolic compounds, and tocopherol were identi-
fied in the two extracts in different concentrations. EEP-S
presented a higher content of amyrins (triterpenes) and 𝛽-
sitosterol (phytosterols), whereas EEP-M exhibited a higher
concentrations of tocopherol, amyrins, and apigenin (flavo-
noid).The compounds stigmasterol, taraxasterol, vanilic acid,
caffeic acid, quercetin, luteolin, and apigenin were found only
in EEP-M.
3.2. Antioxidant Activity
3.2.1. DPPHandABTS Free Radical Scavenging Activity. EEP-
S and EEP-M were observed to scavenge free radicals in
vitro. In both of the evaluatedmethods, EEP-M showed better
antioxidant activity compared with EEP-S. In the DPPH
assay, EEP-M showed 50% inhibition of free radicals (IC
50
)
at a concentration of 60.91 ± 2.01 𝜇g/mL. The IC
50
was not
calculated for EEP-S. The maximum activity of EEP-M was
achieved at a concentration of 300 𝜇g/mL (Table 3).
In the assay with the ABTS radical, IC
50
values of
the EEPs were 80.04 ± 0.31 𝜇g/mL (EEP-S) and 13.45 ±
1.81 𝜇g/mL (EEP-M), and they showed maximal activity at
concentrations of 200𝜇g/mL and 100 𝜇g/mL, respectively.
The antioxidant activity of EEP-M was similar to that of the
synthetic antioxidant BHT (Table 3).
3.2.2. Oxidative Hemolysis Inhibition Assay. The standard
antioxidant ascorbic acid and the EEPs showed concentra-
tion- and time-dependent antihemolytic activity. EEP-S
decreased hemolysis for 120min, with hemolysis inhibition
reaching 63.5 ± 10.7% at a concentration of 125 𝜇g/mL, when
compared with the AAPH sample. At the same concen-
tration, ascorbic acid and EEP-M protected erythrocytes
against hemolysis induced by the oxidant 2,2󸀠-azobis(2-
aminopropane) hydrochloride (AAPH) for up to 240min,
with hemolysis inhibition reaching 56.5 ± 12.8% and 37.7 ±
10.4% at 240min, respectively, compared with erythrocytes
treated with AAPH (Figure 1). At the various concentrations
tested, the basal hemolysis observed using ascorbic acid and
EEPs without the AAPH inducer was similar to the control
treatments with saline and ethanol (data not shown).
3.2.3. Efficiency of EEPs in the Inhibition of AAPH-Induced
Lipid Peroxidation. The effectiveness of EEPs in inhibiting
lipid peroxidation induced by AAPH in human erythrocytes
can be determined by measuring malondialdehyde (MDA)
levels. Ascorbic acid and EEPs decreased MDA levels in a
concentration- and time-dependentmanner. EEP-S inhibited
lipid peroxidation for 180min. The ascorbic acid control
solution inhibited lipid peroxidation by 65.6 ± 8.9%, whereas
EEP-M inhibited peroxidation by 74.4 ± 6.1% for 240min at a
concentration of 125𝜇g/mL, when compared with the AAPH
sample (Figure 2).
3.3. Cytotoxic Activity and Cell Death Profile. The ethanol
extracts of propolis showed concentration-dependent cyto-
toxicity. At the highest concentration tested (500𝜇g/mL),
the cell growth of erythroleukemic cells (K562) were 32.6 ±
3.2% (EEP-S) and 21.2 ± 4.1% (EEP-M) (Figure 3). At this
concentration, after 24 h of treatment, EEP-S promoted death
by necrosis in 52.9 ± 4.1% of cells and death by late apoptosis
in 12.1 ± 0.6% of cells (Figures 4(a) and 4(b)), whereas EEP-
M promoted death by necrosis in 57.5 ± 3.8% of cells and
death by late apoptosis in 19.4 ± 1.6% of cells (Figures 5(a) and
5(b)).
Oxidative Medicine and Cellular Longevity 5
Table 1: Compounds identified in unpolar fraction of the EEPs from Scaptotrigona depilis andMelipona quadrifasciata anthidioides by GC-
MS.
Peak Retention time (min) Compounds Molecular mass EEP-S (mg/g) EEP-M (mg/g)
1 17.02 Stigmasterol∗ 412 — 4.8 ± 0.1
2 17.72 𝛽-Sitosterol∗ 414 9.6 ± 0.2 5.4 ± 0.2
3 17.93 𝛽-Amyrin∗ 426 14.3 ± 0.3 11.6 ± 0.3
4 18.09 Taraxasterol 426 — 3.0 ± 0.1
5 18.45 𝛼-Amyrin∗ 426 10.5 ± 0.3 5.0 ± 0.1
6 19.65 𝛽-Amyrin acetate∗ 468 21.5 ± 0.4 13.7 ± 0.4
7 24.56 Tocopherol∗ 430 3.6 ± 0.1 15.0 ± 0.5
∗Compound was confirmed by comparison of standard.
Data are shown as media ± standard deviation.
Table 2: Compounds identified in polar fraction of the EEPs from Scaptotrigona depilis andMelipona quadrifasciata anthidioides by HPLC.
Peak Retention time (min) Compounds Molecular mass EEP-S (mg/g) EEP-M (mg/g)
1 7.95 Vanilic acid 168 — 5.9 ± 0.1
2 8.64 Caffeic acid 180 — 6.1 ± 0.2
3 10.44 Vanillin 152 5.5 ± 0.2 5.7 ± 0.1
4 13.48 p-Coumaric acid 164 6.3 ± 0.2 6.1 ± 0.2
5 17.28 Ferulic acid 194 5.4 ± 0.2 6.1 ± 0.2
6 19.99 Benzoic acid 122 6.8 ± 0.2 6.9 ± 0.1
7 35.33 Quercetin 302 — 9.9 ± 0.2
8 36.68 Luteolin 286 — 1.3 ± 0.1
9 40.01 Cinnamic acid 148 13.4 ± 0.4 13.2 ± 0.3
10 42.62 Apigenin 270 — 15.6 ± 0.4
∗Compound was confirmed by comparison of standard.
Data are shown as media ± standard deviation.
3.4. Toxicity in C. elegans. EEP-S and EEP-M were not toxic
to the nematodes after 24 h of incubation at any of the
concentrations evaluated compared with the control group
(Figure 6).
4. Discussion
Propolis is a bee product that is widely used in the cosmetics
and food industries and is considered a functional food
(nutraceutical) able to prevent diseases when included in
food products [5]. The chemical constituents present in
propolis are responsible for its therapeutic properties [7, 11,
27], including its antibacterial, antifungal, and antiviral activ-
ities [5, 14] as well as its anti-inflammatory and antitumor
activities [15, 16, 28, 29].
The major compounds identified in the EEP-S were 𝛽-
amyrin, 𝛽-amyrin acetate, and 𝛼-amyrin and in the EEP-
M were tocopherol, 𝛽-amyrin acetate, and apigenin. Both
extracts show similar amounts of 𝛽-amyrin, vanillin, p-
coumaric acid, ferulic acid, cinnamic acid, and benzoic acid;
however, the EEP-S showed higher content of amyrins than
EEP-M. By contrast, EEP-M exhibited approximately four
times the amount of tocopherol found in EEP-S and other
compounds which were found exclusively on the EEP-M.
Despite presenting the same chemical constituents, variations
in the concentrations of these compounds may influence the
biological activities of the extracts.
The compounds phenolic and flavonoid are correlated
with the antioxidant and antitumor activity of propolis [8,
10–12, 30]. Additionally, other compounds identified in the
propolis such as caffeic acid, apigenin, and triterpenes are
descript with important blockers of oncogenic kinase PAK1,
well known to be responsible for a variety of diseases such as
infectious diseases, Alzheimer’s disease, diseases inflamma-
tory, diabetes, hypertension, obesity, and cancer [31].
Phenolic compounds and terpenes have been found in
propolis extracts of other species of stingless bees from the
same geographical region [12, 29], which may be related to
the plant species from which the bees collect raw materials
for propolis production.
The terpenes and phenolic compounds found in EEPs
have been described as compounds responsible for the anti-
oxidant activities of various plant species [32–34]. Antioxi-
dants are compounds that, when present at low concentra-
tions, retard or prevent the oxidation of substrates and are
highly beneficial to health due to protecting cells and macro-
molecules from oxidizing agents [35].
The most common oxidants in the body include the
superoxide (O
2
−), hydroxyl (OH∙), peroxyl (ROO), alkoxyl
(RO), and hydroperoxyl (HO
2
) radicals, which are collec-
tively known as reactive oxygen species (ROS). These free
radicals are produced via gradual reduction ofmolecular oxy-
gen and generate unpaired electrons, which cause oxidative
stress when they are out of equilibrium [36].
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Table 3: IC
50
and maximum DPPH and ABTS radical scavenging activity of standard antioxidants, EEP-S and EEP-M.
Sample
DPPH ABTS
IC
50
(𝜇g/mL) Maximum inhibition IC
50
(𝜇g/mL) Maximum inhibition
% 𝜇g/mL % 𝜇g/mL
Ascorbic acid 3.32 ± 0.65 96.75 ± 0.41 50 2.50 ± 0.48 97.37 ± 1.55 10
BHT 22.84 ± 7.87 89.36 ± 2.30 200 20.46 ± 2.78 95.36 ± 1.80 100
EEP-S ND 14.91 ± 1.73 300 80.04 ± 0.31 73.42 ± 3.47 200
EEP-M 60.91 ± 2.01 97.47 ± 0.03 300 13.45 ± 1.81 99.31 ± 0.12 100
Values are means ± SEM. DPPH (𝑛 = 2) and ABTS (𝑛 = 3). ND: not determined.
Control 50 75 100 125 50 75 100 125 50 75 100 125
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Figure 1: Protective effects of ascorbic acid (standard antioxidant) and ethanol extracts of propolis from S. depilis and M. q. anthidioides
against AAPH-induced hemolysis determined using a human erythrocyte suspension at 120min (a), 180min (b), and 240min (c). Ethanol
was employed as a negative control. The results are expressed as the mean ± SEM (standard error of the mean), 𝑛 = 5. ∗Significantly different
(𝑝 < 0.05) compared with the AAPH group.
Both EEPs stabilized the free radicals 2,2-diphenyl-1-
picrylhydrazyl (DPPH) and 2,2󸀠-azino-bis(3-ethylbenzothia-
zoline-6-sulfonic acid) (ABTS). However, EEP-M showed
higher antioxidant activity than EEP-S, which may be related
to the different concentrations of tocopherol in the extracts.
Some studies have reported the importance of tocopherols as
antioxidants [37, 38].
In addition, the amyrins may be associated with the anti-
oxidant activity of the extracts. Tocopherols and these triter-
penes are fat-soluble antioxidants that scavenge ROS [34, 39,
40]. These compounds may have been responsible for the
increased antioxidant activity of the EEPs observed in the
assay with the free radical ABTS, as this method is applied
to hydrophilic and lipophilic antioxidant systems [41].
Therefore, the higher solubility of these compounds in the
solvent used in this assay produced greater antioxidant
activity.
These results corroborate those obtained in the assays
involving the inhibition of lipid peroxidation, in which
the EEPs presented antihemolytic activity and protective
activity against lipid peroxidation when incubated with
human erythrocytes in the presence of an oxidizing agent.
EEPs may also inhibit the peroxyl radical (ROO), which
induces peroxidation of lipids and proteins present in human
erythrocyte membranes [42].
Oxidative stress leads to lipid peroxidation and, conse-
quently, cell damage due to the oxidation of essential cellular
compounds, including lipids, proteins, and nucleic acids. An
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Figure 2: Protective effects of ascorbic acid (standard antioxidant) and ethanol extracts of propolis from S. depilis and M. q. anthidioides
against the production of malondialdehyde (MDA)–a byproduct of lipid peroxidation–in a human erythrocyte suspension at 120min (a),
180min (b), and 240min (c). Ethanol was used as a negative control. The results are expressed as the mean ± SEM (standard error of the
mean), 𝑛 = 3. ∗Significantly different (𝑝 < 0.05) compared with the AAPH group.
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Figure 3: Cytotoxic activity of EEPs from S. depilis (EEP-S) andM.
q. anthidioides (EEP-M) against the K562 erythroleukemia cell line.
∗𝑝 < 0.05 for the treated group versus control viable cells.
excess of these free radicals can promote cell aging and the
development of various diseases, including Alzheimer’s, can-
cer, arthritis, and diabetes, and can increase the risk of cardio-
vascular disease [36, 43].
Therefore, the evaluated EEPs contain important antioxi-
dant compounds that can limit the spread of oxidative stress-
related diseases. The free radicals scavenging and antihemo-
lytic ability demonstrated by the EEP-M were more efficient
than results observed for propolis from the stingless bee
Tetragonisca fiebrigi [29] and Melipona orbignyi [12] from
Midwest Region of Brazil and some extracts of Apis mellifera
[44, 45].
In the present study, EEP-S and EEP-M exhibited cyto-
toxic activity against K562 erythroleukemic cells. In addition,
the decrease in cell viability was greater in cells treated with
EEP-M than in those treatedwith EEP-S.However, both EEPs
caused necrosis in most of the cells at a concentration of
500 𝜇g/mL.The cytotoxic effect of propolis was also observed
in other cell lines as human lung adenocarcinoma epithe-
lial (A549), human cervical adenocarcinoma (HeLa), and
human breast adenocarcinoma (MCF-7) but themechanisms
involved in the death of these tumor cells were apoptosis [46–
48].Therefore, the use of EEP-S andEEP-Mmay constitute an
alternative treatment for chronic myeloid leukemia, as K562
cells are resistant to apoptosis induced by various agents [49].
Some compounds found in EEPs may play an impor-
tant role in anticancer activity, including tocopherol, which
shows antitumor activity in esophageal cancer cells [50] and
breast cancer in vitro and in vivo [51]. Furthermore, caffeate
derivatives are cytotoxic against human carcinoma cell lines
[52].
Other phenolic compounds present in propolis exhibit
antiproliferative and cytotoxic effects against various tumor
cell lines, including those obtained from renal cell carcinomas
[53] and the colon [30], pancreas [54], skin [55], and lungs
[56]. Amyrins can be isolated from plants and is known as
natural potent anticancer; its compounds induces tumor cell
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Figure 4: Cytotoxic action of EEP from S. depilis against the K562 erythroleukemia cell line. (a) Representative diagrams obtained
via flow cytometry of cells stained with annexin V-FITC/PI: the lower left quadrant (PI−/An−) represents viable cells; the lower right
quadrant (PI−/An+) represents apoptotic cells; the upper left quadrant (PI+/An−) represents cells undergoing necrosis; and the upper right
quadrant (PI+/An+) represents cells in late apoptosis. (b) Frequency of cell death, obtained from the corresponding diagrams for the tested
concentrations. ∗𝑝 < 0.05 for the treated group versus control viable cells. ∗∗𝑝 < 0.05 for the treated group versus control apoptosis. #𝑝 < 0.05
for the treated group versus control necrosis. +𝑝 < 0.05 for the treated group versus control late apoptosis.
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Figure 5: Cytotoxic action of EEP fromM. q. anthidioides against the K562 erythroleukemia cell line. (a) Representative diagrams obtained
via flow cytometry of cells stainedwith annexinV-FITC/PI: the lower left quadrant (PI−/An−) represents viable cells; the lower right quadrant
(PI−/An+) represents apoptotic cells; the upper left quadrant (PI+/An−) represents cells in necrosis; and the upper right quadrant (PI+/An+)
represents cells in late apoptosis. (b) Frequency of cell death, obtained from the corresponding diagrams for the tested concentrations. ∗𝑝 <0.05 for the treated group versus control viable cells. ∗∗𝑝 < 0.05 for the treated group versus control apoptosis. #𝑝 < 0.05 for the treated group
versus control necrosis. +𝑝 < 0.05 for the treated group versus control late apoptosis.
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Figure 6: Toxicity of EEPs from S. depilis EEP-S and M. q.
anthidioides (EEP-M) against C. elegans. ∗𝑝 < 0.05 for the treated
group versus the control with untreated nematodes.
death as human bladder carcinoma (NTUB1) [34, 57] and
leukemia cells (HL-60) [58].
Although the EEPs presented cytotoxic activity against
K562 cells, no toxic or lethal effects were observed against the
nematode C. elegans.
In vivo experimental models serve as a tool to understand
effects of natural products in whole organisms. These results
suggest that the evaluated propolis samples show specificity
against leukemic cells, considering that these nematodeswere
not affected. This specificity may be important for the treat-
ment of leukemia because drug toxicity and low specificity are
among the major difficulties in the treatment of this disease
[37].
Corroborating with the toxicity data of the EEPs, recent
study showed that the crude extract of propolis presented
anticancer effects in human lung cancer cell and is antime-
lanogenic in themelanoma cell line; additionally it was able to
prolong the life ofC. elegans [48]. In addition, the caffeic acid,
themajor constituent of propolis, does no present toxic effects
and also was able to increase the survival of the nematode
C. elegans after infection with the fungal pathogen [59]. The
ability of propolis or caffeic acid to extend lifespan in C.
elegans was associated with inactivation of oncogenic kinase
PAK1 [48, 59].
Previous studies have shown thatC. elegans can be used as
an experimental model for obtaining rapid results in toxicity
studies for pharmacological compounds [60, 61] because it is
a multicellular organism with a high reproduction rate and
short life cycle, which makes it an excellent in vivo model for
complementing cell culture-based systems [61].
Therefore, we conclude that the tested EEPs exhibit
antioxidant and cytotoxic activities, attributed to their chem-
ical composition, which includes phytosterols, terpenes,
phenolic compounds, and tocopherol, and possibly to the
synergy between different compounds present in propolis.
Moreover, these EEPs show therapeutic potential for use in
the prevention and treatment of diseases associated with
oxidative stress and the proliferation of tumor cells.
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